G2TT
来源类型Report
规范类型报告
来源IDRR-240-DH
Pharmaceutical pricing: The use of external reference pricing
Kai Ruggeri; Ellen Nolte
发表日期2013-06-04
出版年2013
页码59
语种英语
结论 Pharmaceutical pricing: The use of external reference pricing | RAND
摘要

External reference pricing, or international price comparison, is a common strategy to control prices of pharmaceuticals that are protected by intellectual property rights and benefit from a legal monopoly (in-patent drugs). In the UK negotiations are under way that seek to define new arrangements for the pricing of branded (new) medicines from 2014. The pharmaceutical market in the UK only accounts for a small proportion of global sales; however, UK prices are important as many countries reference their prices against those in the UK. This report seeks to contribute to our understanding of approaches to pharmaceutical pricing in high-income countries and the role of reference pricing as a means to determining pharmaceutical prices. Reviewing experiences in Canada, France, Germany, Italy, the Netherlands and Spain, we find high variability of external reference pricing across different settings and of the relative importance of this approach in comparison with other pricing strategies. There was also considerable variation in the terminology and practices used, and understanding the complexities of countries included in reference baskets for external pricing requires considerable semantic clarification. There was considerable overlap between countries that cross-reference, and it remains challenging to estimate the direct, immediate impact on external reference baskets. This review suggests that the international impact of pricing changes in the UK is likely to be minimal or indirect, largely because of the diverse ways in which reference pricing is implemented in the countries examined.

目录
  • Chapter One

    Introduction

  • Chapter Two

    Overview of findings

  • Chapter Three

    Country profiles

  • Appendix One

    Country questionnaire

主题Canada ; France ; Germany ; Health Care Costs ; Health Care Price Competition ; Italy ; Netherlands ; Pharmaceutical Drugs ; Spain
URLhttps://www.rand.org/pubs/research_reports/RR240.html
来源智库RAND Corporation (United States)
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/522281
推荐引用方式
GB/T 7714
Kai Ruggeri,Ellen Nolte. Pharmaceutical pricing: The use of external reference pricing. 2013.
条目包含的文件
文件名称/大小 资源类型 版本类型 开放类型 使用许可
RAND_RR240.pdf(482KB)智库出版物 限制开放CC BY-NC-SA浏览
x1495315145413.jpg.p(1KB)智库出版物 限制开放CC BY-NC-SA浏览
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Kai Ruggeri]的文章
[Ellen Nolte]的文章
百度学术
百度学术中相似的文章
[Kai Ruggeri]的文章
[Ellen Nolte]的文章
必应学术
必应学术中相似的文章
[Kai Ruggeri]的文章
[Ellen Nolte]的文章
相关权益政策
暂无数据
收藏/分享
文件名: RAND_RR240.pdf
格式: Adobe PDF
文件名: x1495315145413.jpg.pagespeed.ic.q9NUsTWYFS.jpg
格式: JPEG

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。